Joachim Wernicke und Duloxetine - Info zur Person

(1 - 16 von 16

)

Duloxetine effective for diabetic neuropathic pain | Reuters

www.reuters.com

Duloxetine appears to be a safe and effective treatment for diabetes-related pain caused by damage to the peripheral nervous system, according to a report in...

WikiGenes - Joachim Wernicke

www.wikigenes.org

Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions. Wernicke, J.F. ...

Software to find, classify, and report on data patterns and arrhythmiasjournals.scholarsportal.info › details

journals.scholarsportal.info

An Evaluation of the Cardiovascular Safety Profile of Duloxetine: Findings from 42 Placebo-Controlled Studies. Authors. Joachim Wernicke · Alberto Lledó ...

Safety and tolerability of duloxetine treatment of diabetic...

www.sciencedirect.com

Joachim Wernicke, Apurva Prakash, Daniel Kajdasz, and John Houston are stock shareholders and full-time employees of Eli Lilly and Company. Previous ...

Hepatic Effects of Duloxetine-I: Non-Clinical and Clinical Trial Datawww.ingentaconnect.com › content › ben › cds › art00006

www.ingentaconnect.com

Joachim Wernicke. *,1. , Beth Pangallo. 1. , Fujun Wang. 1. , Isabelle Murray. 1. , Judith W. Henck. 1. ,. Mary Pat Knadler. 1. , Deborah N. D'Souza. 1 and Jack ...

An Evaluation of the Cardiovascular Safety Profile of Duloxetine |...

link.springer.com

Joachim Wernicke,1 Alberto Lledó,2 Joel Raskin,3 Daniel K. Kajdasz1 and Fujun Wang1. 1 Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, ...

A retrospective pooled analysis of duloxetine safety in 23,

pubmed.ncbi.nlm.nih.gov

The safety profile for the molecule from the overall duloxetine exposures integrated safety database suggests that benign and common pharmacologic side effects...

An evaluation of the cardiovascular safety profile of duloxetine ...

go.gale.com

von J Wernicke · · Zitiert von: 157 — Gale OneFile includes An evaluation of the cardiovascular safety profile of d by Joachim Wernicke, Alberto Lledo, Joel R. Click to explore. › i.do

Efficacy of Duloxetine in Patients with Chronic Pain PubMedpubmed.ncbi.nlm.nih.gov › ...

pubmed.ncbi.nlm.nih.gov

... Joachim Wernicke. Affiliation. 1 Lilly Research Laboratories, Indianapolis, IN , USA. PMID: ; PMCID: PMC ; DOI:

Efficacy of Duloxetine in Patients with Chronic Pain Conditionswww.eurekaselect.com › article

www.eurekaselect.com

... Joachim Wernicke. Volume 6, Issue 4, Page: [ ] Pages: 8. DOI: Download Article. Abstract. The primary objective of ...

Hepatic Effects of Duloxetine-II: Spontaneous Reports and...

www.eurekaselect.com

Objective: Review spontaneous reports and epidemiology of hepatic events associated with duloxetine. Methods: Spontaneous reports of adverse events poten

Hepatic Effects of Duloxetine-II: Spontaneous Reports and ...benthamscience.com › article

benthamscience.com

65,00 $Author(s): Joachim Wernicke, Nayan Acharya, Indiana Strombom, James L. Gahimer, Deborah N. D'Souza, Natalie DiPietro and Jack P. Uetrecht. 65,00 $ Author(s): Joachim Wernicke, Nayan Acharya, Indiana Strombom, James L. Gahimer, Deborah N. D'Souza, Natalie DiPietro and Jack P. Uetrecht.

Dirk Mahlitz
Dietrich Enss

Person "Wernicke" (10)
Vorname "Joachim" (33841)
Name "Wernicke" (697)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Joachim Wernicke und Duloxetine Person-Info